Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-057007

Chief Business Development Off sold 6,772 shares at an average $45.58 ($308,642)

  • Chief Business Development Off acquired 6,772 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +2,605 $6.55 $17,063 2,605 D
2020-11-02 Exercise or conversion : show line 2 in the form +2,604 $6.55 $17,056 5,209 D
2020-11-02 Exercise or conversion : show line 3 in the form +1,563 $7.27 $11,363 6,772 D
2020-11-02 Sale : show line 4 in the form −5,698 $45.47 $259,088 1,074 D
2020-11-02 Sale : show line 5 in the form −1,074 $46.14 $49,554 0 D
Open-market sales · 6,772 sh · avg $45.58 · $308,642

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-11-02 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,605 31,250 D
2020-11-02 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,604 59,896 D
2020-11-02 Exercise or conversion : show line 8 in the form Common Stock (Right to Buy) −1,563 40,625 D
Loading xslF345X03/doc4.xml…